Genies Introduces Emojis That React To Current Events
Genies is a new app that launched late last year which allows users to create personalizable look-alike and expressive emojis that react to what’s going on in real-time -- everything from breaking news to cultural holidays. CEO Akash Nigam sits down with Cheddar to talk about what went into creating the app, including the company's proprietary AI technology designed to make the app the first of its kind.
Nigam acknowledged that the emoji space is becoming more saturated, but insists Genie is creating something that will stand out from the crowd. The young CEO, who was nominated for Forbes 30 under 30 in 2016, recently raised $15 million in investor funding to further develop the technology.
He also discusses the value of having celebrities like Shawn Mendes and Chainsmokers attached to the brand as investors and celebrity ambassadors. Nigam says the company plans to make Bitmoji obsolete with its new upgraded technology.
We spoke with a farmer about how tariffs, trade policy, drought, and packer consolidation are reshaping the economics of American ranching and farming.
John Serafini, CEO of Hawkeye 360, breaks down the company’s 87% revenue growth, global demand for space-based intelligence and plans to scale its business.
Dan Niles, Founder and Portfolio Manager at Niles Investment Management, breaks down NVIDIA’s blowout earnings, 70% growth forecast and AI spending boom.
Edwin Cywinski, CEO of SunScout Holding Limited, explains how solar-powered robotic mowers are transforming lawn care and the company’s plans to scale.
Nathan Bomey, Business Reporter at Axios and author of The Axios Closer newsletter, explains why Wall Street is turning NVIDIA’s AI chips into financial assets.
Jamie Siminoff, Founder and Chief Inventor of Ring, explains the company’s new TAKE encryption standard and its push to put privacy and video data control first
Xavier Martinez, News Associate at The Wall Street Journal, breaks down Moderna’s mRNA ambitions, its pipeline beyond COVID-19 and the challenges ahead.